These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22995210)

  • 41. Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors.
    Marchetti M; Monier MN; Fradagrada A; Mitchell K; Baychelier F; Eid P; Johannes L; Lamaze C
    Mol Biol Cell; 2006 Jul; 17(7):2896-909. PubMed ID: 16624862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells.
    Xiao W; Klement JD; Lu C; Ibrahim ML; Liu K
    J Immunol; 2018 Jul; 201(1):264-277. PubMed ID: 29752314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Down syndrome and type I interferon: not so simple.
    Malle L; Bogunovic D
    Curr Opin Immunol; 2021 Oct; 72():196-205. PubMed ID: 34174697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-α autoamplification.
    Teijaro JR; Studer S; Leaf N; Kiosses WB; Nguyen N; Matsuki K; Negishi H; Taniguchi T; Oldstone MB; Rosen H
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1351-6. PubMed ID: 26787880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor.
    Cho IR; Oh M; Koh SS; Malilas W; Srisuttee R; Jhun BH; Pellegrini S; Fuchs SY; Chung YH
    Int J Mol Med; 2012 Apr; 29(4):581-6. PubMed ID: 22218495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salt suppresses IFNγ inducible chemokines through the IFNγ-JAK1-STAT1 signaling pathway in proximal tubular cells.
    Arai Y; Takahashi D; Asano K; Tanaka M; Oda M; Ko SBH; Ko MSH; Mandai S; Nomura N; Rai T; Uchida S; Sohara E
    Sci Rep; 2017 Apr; 7():46580. PubMed ID: 28425456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IFN-γ Induces IL-15
    Kim TS; Rha MS; Shin EC
    J Immunol; 2022 Jan; 208(2):338-346. PubMed ID: 34893528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional crosstalk between type I and II interferon through the regulated expression of STAT1.
    Gough DJ; Messina NL; Hii L; Gould JA; Sabapathy K; Robertson AP; Trapani JA; Levy DE; Hertzog PJ; Clarke CJ; Johnstone RW
    PLoS Biol; 2010 Apr; 8(4):e1000361. PubMed ID: 20436908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impacts of the STING-IFNAR1-STAT1-IRF1 pathway on the cellular immune reaction induced by fractionated irradiation.
    Du J; Kageyama SI; Yamashita R; Hirata H; Hakozaki Y; Okumura M; Motegi A; Hojo H; Nakamura M; Hirano Y; Sunakawa H; Minamide T; Kotani D; Tanaka K; Yano T; Kojima T; Ohashi A; Tsuchihara K; Akimoto T
    Cancer Sci; 2022 Apr; 113(4):1352-1361. PubMed ID: 35133062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Down modulation of IFN-gamma signaling in alveolar macrophages isolated from smokers.
    Dhillon NK; Murphy WJ; Filla MB; Crespo AJ; Latham HA; O'Brien-Ladner A
    Toxicol Appl Pharmacol; 2009 May; 237(1):22-8. PubMed ID: 19269302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene.
    Ramsauer K; Farlik M; Zupkovitz G; Seiser C; Kröger A; Hauser H; Decker T
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2849-54. PubMed ID: 17293456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations.
    Hoyos-Bachiloglu R; Chou J; Sodroski CN; Beano A; Bainter W; Angelova M; Al Idrissi E; Habazi MK; Alghamdi HA; Almanjomi F; Al Shehri M; Elsidig N; Alaa Eldin M; Knipe DM; AlZahrani M; Geha RS
    J Clin Invest; 2017 Dec; 127(12):4415-4420. PubMed ID: 29106381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosis.
    Deckx N; Willekens B; Wens I; Eijnde BO; Goossens H; Van Damme P; Berneman ZN; Cools N
    Innate Immun; 2016 May; 22(4):266-73. PubMed ID: 27036414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dimerization of the interferon type I receptor IFNaR2-2 is sufficient for induction of interferon effector genes but not for full antiviral activity.
    Pattyn E; Van Ostade X; Schauvliege L; Verhee A; Kalai M; Vandekerckhove J; Tavernier J
    J Biol Chem; 1999 Dec; 274(49):34838-45. PubMed ID: 10574956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A conserved IFN-alpha receptor tyrosine motif directs the biological response to type I IFNs.
    Zhao W; Lee C; Piganis R; Plumlee C; de Weerd N; Hertzog PJ; Schindler C
    J Immunol; 2008 Apr; 180(8):5483-9. PubMed ID: 18390731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type I Interferon Activates PD-1 Expression through Activation of the STAT1-IRF2 Pathway in Myeloid Cells.
    Liang L; Yang Y; Deng K; Wu Y; Li Y; Bai L; Wang Y; Lu C
    Cells; 2024 Jul; 13(13):. PubMed ID: 38995014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MEK1/2 Inhibitors Unlock the Constrained Interferon Response in Macrophages Through IRF1 Signaling.
    Yang L; Ding JL
    Front Immunol; 2019; 10():2020. PubMed ID: 31507609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The endogenous interferon system in anal squamous epithelial lesions with different grades from HIV-positive individuals.
    Arany I; Muldrow M; Tyring SK
    Int J STD AIDS; 2001 Apr; 12(4):229-33. PubMed ID: 11319973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors.
    Tao Q; Liu N; Wu J; Chen J; Chen X; Peng C
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38471712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Susceptibility to Heart Defects in Down Syndrome Is Associated with Single Nucleotide Polymorphisms in HAS 21 Interferon Receptor Cluster and VEGFA Genes.
    Balistreri CR; Ammoscato CL; Scola L; Fragapane T; Giarratana RM; Lio D; Piccione M
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.